ProMed Pharma, LLC, a division of ProMed Molded Products, Inc. specializes in the combining and molding of active pharmaceuticals into components that meet our customer’s requirements. Dedicated quality system, facilities and personnel support the activities necessary to develop and manufacture these drug eluting components. Working with both established and early-stage medical device and pharmaceutical companies, we develop robust manufacturing processes and platforms for the controlled release of drugs from a variety of materials.
Find out more about our material characterization and quality assurance.
Representative drug-device applications include steroid-eluting pacing and defibrillation leads, drug-eluting stents and balloons, antimicrobial catheters, and wound or joint spacers. ProMed also supports pharmaceutical companies developing extended-release formulations utilizing subcutaneous implants, intrauterine devices, vaginal rings, and ophthalmic implants. Typical active pharmaceutical ingredients encountered include hormones, microbicides, and other small molecules.
Silicones have a well-established history of use in implantable devices, combination products, and solid implants. At ProMed, we have leveraged over 25 years of manufacturing experience with silicones to provide a wide range of drug-eluting components. Partnerships with leading suppliers give us access to world-class implantable materials and expertise to ensure the safety and performance of your product. ProMed is working to expand the range of molded drug-eluting material offerings to include PMMA (poly(methyl methcacrylate)), EVA (ethylene vinyl acetate), and PEEK (Polyhether ether ketone) as well as resorbable materials such as PLGA (poly(lactic-co-glycolic acid)).